DBDurga Prasad Beda

Durga Prasad Beda

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Durga Prasad Beda has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Innovative Non-Pharmacological Therapies for SARS-CoV-2 Infections: Advances, Challenges and Future Directions

    by Gatadi Srikanth, Santoshachandra Rao Karanam, Bhabani Sankar Satapathy, Parul Thapar, Durga Prasad Beda, Jitendra Patel

    The COVID-19 pandemic has necessitated diverse therapeutic approaches, including drug-free therapies to complement pharmaceutical interventions. This review examines the current landscape, challenges and future perspectives of non-drug therapies for COVID-19. Critical approaches include oxygen therapy, mechanical ventilation, prone positioning, physical therapy, nutritional support, psychological support, hydration management and alternative therapies such as acupuncture and phototherapy. Despite their potential, these therapies face significant challenges, including disease variability, resource limitations, patient-specific factors, infection control issues and the need for robust clinical evidence. Future perspectives highlight the technological advancements such as telehealth, wearable devices and artificial intelligence; improved respiratory support systems; integrated multidisciplinary care; extensive public health initiatives; stringent clinical trials; personalized medicine; global health equity; mental health integration; lifestyle modifications and preparedness for future pandemics. Addressing these challenges and leveraging advancements will enhance the effectiveness and accessibility of drug-free therapies, improving patient outcomes and bolstering healthcare resilience against future pandemics.

  • Open Access

    Exploring New Frontiers in Alternative Medicine: Insights and Perspectives

    by Veeresh Pratap, Durga Prasad Beda

    This paper examines the rise of alternative medicine, explores its new frontiers, and provides important insights and perspectives. Alternative medicine has become an important complement to traditional medical practices due to the increasing number of people seeking a holistic approach to health, and it is natural this research examines various alternative therapies, such as acupuncture, herbs, chiropractic care, and homeopathy, and tests their effectiveness, safety, and integration into and management of primary health care, e.g., legal issues, scientific evidence, and ability to integrate with traditional medicine. Through a comprehensive review of recent research, expert opinion, and case studies, this paper aims to provide nuanced understandings of the potential and limitations of alternative medicine and highlight its role in the health of the future of the emphasis. The insights gleaned from this study may provide valuable perspectives for health care providers, researchers, and patients considering alternative therapies.

  • Open Access

    Repurposed Drugs: Current Trends in Drug Discovery

    by Gatadi Srikanth, Durga Prasad Beda, Niggula Praveen Kumar

    Drug repurposing is a drug discovery strategy that involves identifying new therapeutic uses for existing drugs. Drug repurposing relies on the idea that a limited number of genes or gene products mediate biological processes and that several biological entities—such as transcripts, proteins, and genes—have pleiotropic effects and mediate similar tasks. Recently, drug repurposing has gained attention as a different approach that looks for novel uses for previously approved or rejected commercial medications to address conditions other than those they were designed for. It offers numerous benefits, such as faster development timelines, reduced costs, established safety profiles, and the potential for novel treatments for unmet medical needs. This chapter explains the current trends in drug discovery and future perspectives on repurposed drugs.


  • Open Access

    Characterization of Prasugrel Degradation Profile by Several Oxidative Reagents using HPLC and LC-MS/MS Technique

    by Vijay Nayak Bhukya, Durga Prasad Beda

    Prasugrel, a derivative of thienopyridine functions as a prodrug that exerts irreversible inhibition on platelet ADP receptors by specifically targeting the P2Y12 receptor. In pharmaceuticals, the stability of the product plays a crucial role in establishing the shelf life of product. The second common degradation pathway next to hydrolysis is the oxidation. In practice, the oxidative stress studies were carried out using hydrogen peroxide (H2O2), free radicals, oxygen purging, transition metals, singlet oxygen, Fenton reagent, etc. This study compares the oxidative degradation behaviour of prasugrel hydrochloride using different oxidative stressors and was analyzed by HPLC using a method that could separate degradation products individually and from the drug. The degradation products formed under different stress conditions were characterized using LC-TOF-MS/MS. Analysis of accelerated stability samples of prasugrel formulation revealed that the degradation products formed under azobisisobutyronitrile (AIBN) and H2O2 stress conditions were simulated with the stability data. This study on prasugrel showed that the degradation products formed with H2O2 were also observed under hydrolytic conditions. In the pharmaceutical industry, H2O2 is the only oxidative stressor (< 95%) used to study the oxidation degradation of the sample. The present work has demonstrated that AIBN serves as a valuable oxidative stressor for accurately assessing the oxidative stability of drug.